Cherny Robert A. Legg Jacinta T. McLean Catriona A. Fairlie David P. Huang Xudong. Atwood Craig S. Beyreuther Konrad. Tanzi Rudolph E. Masters Colin L. Bush Ashley I [a]. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. Journal of Biological Chemistry. 274(33). Aug. 13, 1999. 23223-23228.

Abstract

Zn(II) and Cu(II) precipitate Abeta in vitro into insoluble aggregates that are dissolved by metal chelators. We now report evidence that these biometals also mediate the deposition of Abeta amyloid in Alzheimer's disease, since the solubilization of Abeta from post-mortem brain tissue was significantly increased by the presence of chelators, EGTA, N,N,N',N'-tetrakis(2-pyridyl-methyl) ethylene diamine, and bathocuproine. Efficient extraction of Abeta also required Mg(II) and Ca(II). The chelators were more effective in extracting Abeta from Alzheimer's disease brain tissue than age-matched controls, suggesting that metal ions differentiate the chemical architecture of amyloid in Alzheimer's disease. Agents that specifically chelate copper and zinc ions but preserve Mg(II) and Ca(II) may be of therapeutic value in Alzheimer's disease.



Return to
Amyloid Beta Deposition and Aggregation References